Elagolix (ABT-620) is an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis and uterine fibroids.

Type of Molecule

Small Molecule

Target

GnRH

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Endometriosis New Indication Phase 3
Uterine Fibroids New Indication Phase 3